Trading a MMED straddle lets you take a pure volatility position on MiniMed Group Inc without committing to a direction. MiniMed Group Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate MMED straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on MMED profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when MiniMed Group Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the MMED straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the MMED straddle is the cleanest expression of that view. Our scanner prices every MMED straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a MMED straddle into a catalyst or short a MMED straddle to harvest decay, the options straddle setups that matter are all in one place.
